Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
DRD.JO Stock Summary
Top 10 Correlated ETFs
DRD.JO
In the News
DRD.JO Financial details
Company Rating
Strong Buy
Market Cap
15.08B
Income
2.24B
Revenue
9.89B
Book val./share
7.32
Cash/share
1.78
Dividend
0.85
Dividend %
0.06%
Employees
927
Optionable
No
Shortable
Yes
Earnings
14 Feb 2024
P/E
0.97
Forward P/E
-
PEG
0.02
P/S
2.34
P/B
0.2
P/C
921.91
P/FCF
25.21
Quick Ratio
3.44
Current Ratio
4.47
Debt / Equity
0
LT Debt / Equity
-
-
-
EPS (TTM)
6.46
EPS next Y
-
EPS next Q
-
EPS this Y
13.74%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
65.5%
Revenue last 5Y
14.75%
Revenue Q/Q
4.65%
EPS Q/Q
-21.84%
-
-
-
-
SMA20
9.57%
SMA50
10.75%
SMA100
3.26%
Inst Own
-
Inst Trans
-
ROA
16%
ROE
21%
ROC
0.18%
Gross Margin
29%
Oper. Margin
25%
Profit Margin
23%
Payout
40%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1200.0-2546.0
52W High
-35.55%
52W Low
+36.75%
RSI
57
Rel Volume
1.03
Avg Volume
783.55K
Volume
806.87K
Perf Week
-0.91%
Perf Month
13.88%
Perf Quarter
-3.47%
Perf Half Y
-4.98%
-
-
-
-
Beta
1.353
-
-
Volatility
44.91%, 75.08%
Prev Close
0.37%
Price
1641
Change
1.61%
DRD.JO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.16 | 5.44 | 6.16 | 5.97 | 6.39 | |
Net income per share | 0.12 | 0.82 | 1.68 | 1.31 | 1.49 | |
Operating cash flow per share | 0.43 | 1.47 | 1.84 | 1.75 | 1.93 | |
Free cash flow per share | -0.09 | 1.23 | 1.38 | 1.07 | 0.59 | |
Cash per share | -0.51 | 1.41 | 1.79 | 2.11 | 2.86 | |
Book value per share | 4.05 | 5.25 | 5.64 | 6.35 | 7.3 | |
Tangible book value per share | 4.05 | 5.25 | 5.64 | 6.35 | 7.3 | |
Share holders equity per share | 4.05 | 5.25 | 5.64 | 6.35 | 7.3 | |
Interest debt per share | 0.13 | 0.15 | 0.13 | 0.15 | 0.13 | |
Market cap | 2.74B | 20.75B | 12.77B | 8.46B | 17.13B | |
Enterprise value | 2.48B | 19.08B | 10.64B | 5.99B | 14.71B | |
P/E ratio | 34.96 | 32.68 | 8.87 | 7.52 | 13.37 | |
Price to sales ratio | 0.99 | 4.96 | 2.42 | 1.65 | 3.12 | |
POCF ratio | 9.52 | 18.38 | 8.11 | 5.65 | 10.35 | |
PFCF ratio | -46.44 | 21.89 | 10.84 | 9.25 | 33.56 | |
P/B Ratio | 1.02 | 5.14 | 2.65 | 1.55 | 2.73 | |
PTB ratio | 1.02 | 5.14 | 2.65 | 1.55 | 2.73 | |
EV to sales | 0.9 | 4.56 | 2.02 | 1.17 | 2.68 | |
Enterprise value over EBITDA | 7.02 | 14.47 | 4.66 | 3.68 | 7.84 | |
EV to operating cash flow | 8.59 | 16.9 | 6.76 | 4 | 8.89 | |
EV to free cash flow | -41.9 | 20.13 | 9.04 | 6.56 | 28.82 | |
Earnings yield | 0.03 | 0.03 | 0.11 | 0.13 | 0.07 | |
Free cash flow yield | -0.02 | 0.05 | 0.09 | 0.11 | 0.03 | |
Debt to equity | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Debt to assets | 0 | 0.01 | 0.01 | 0.01 | 0 | |
Net debt to EBITDA | -0.76 | -1.27 | -0.93 | -1.51 | -1.29 | |
Current ratio | 1.43 | 2.94 | 5.03 | 4.92 | 4.47 | |
Interest coverage | 1.6 | 13.63 | 30.85 | 17.93 | 20.21 | |
Income quality | 2.74 | 1.15 | 1.09 | 1.33 | 1.29 | |
Dividend Yield | 0 | 0.03 | 0.05 | 0.06 | 0.03 | |
Payout ratio | 0 | 0.89 | 0.45 | 0.46 | 0.4 | |
Sales general and administrative to revenue | 0.03 | 0.07 | 0.01 | 0.03 | 0.03 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.68 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -1.2 | -0.16 | -0.25 | -0.39 | -0.69 | |
Capex to revenue | -0.13 | -0.04 | -0.08 | -0.11 | -0.21 | |
Capex to depreciation | -2.05 | -0.67 | -1.57 | -2.18 | -5.27 | |
Stock based compensation to revenue | 0.01 | 0.05 | -0.01 | 0 | 0 | |
Graham number | 3.28 | 9.87 | 14.61 | 13.69 | 15.65 | |
ROIC | 0.03 | 0.15 | 0.27 | 0.18 | 0.17 | |
Return on tangible assets | 0.06 | 0.11 | 0.23 | 0.16 | 0.16 | |
Graham Net | -2.26 | -0.35 | 0.32 | 0.55 | 1.03 | |
Working capital | 197.9M | 1.44B | 2.14B | 2.45B | 2.5B | |
Tangible asset value | -90.2M | 4.04B | 4.82B | 5.44B | 6.27B | |
Net current asset value | -715.3M | 554.8M | 1.15B | 1.44B | 1.33B | |
Invested capital | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Average receivables | 81.6M | 111.65M | 143.3M | 139.1M | 136.5M | |
Average payables | 361.2M | 449M | 415.85M | 391M | 477.1M | |
Average inventory | 268.8M | 314M | 331.7M | 364.65M | 401.45M | |
Days sales outstanding | 9.51 | 13.2 | 9.37 | 10.19 | 8.64 | |
Days payables outstanding | 59.91 | 59.49 | 38.02 | 41.86 | 49.01 | |
Days of inventory on hand | 43.53 | 40.18 | 36.63 | 37.98 | 38.6 | |
Receivables turnover | 38.36 | 27.66 | 38.94 | 35.82 | 42.25 | |
Payables turnover | 6.09 | 6.14 | 9.6 | 8.72 | 7.45 | |
Inventory turnover | 8.38 | 9.08 | 9.97 | 9.61 | 9.46 | |
ROE | 0.03 | 0.16 | 0.3 | 0.21 | 0.2 | |
Capex per share | -0.52 | -0.24 | -0.46 | -0.68 | -1.33 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q2
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 15.43 | 3.09 | 16.35 | 3.3 | 3.45 | |
Net income per share | 3.11 | 0.62 | 4.29 | 0.87 | 0.68 | |
Operating cash flow per share | 3.7 | 0.74 | 5.86 | 1.18 | 0.86 | |
Free cash flow per share | 1.45 | 0.29 | 1.5 | 0.3 | -0.39 | |
Cash per share | 27.81 | 2.79 | 28.43 | 2.87 | 1.78 | |
Book value per share | 65.46 | 6.56 | 72.17 | 7.29 | 7.32 | |
Tangible book value per share | 65.46 | 6.56 | 72.17 | 7.29 | 7.32 | |
Share holders equity per share | 65.46 | 6.56 | 72.17 | 7.29 | 7.32 | |
Interest debt per share | 0 | 0.03 | 0 | 0.03 | 0.03 | |
Market cap | 846.37M | 10.49B | 1.48B | 17.15B | 13.58B | |
Enterprise value | -1.55B | 8.14B | -990M | 14.72B | 12.08B | |
P/E ratio | 0.79 | 4.9 | 0.99 | 5.75 | 5.76 | |
Price to sales ratio | 0.64 | 3.95 | 1.04 | 6.04 | 4.57 | |
POCF ratio | 2.66 | 16.47 | 2.91 | 16.84 | 18.44 | |
PFCF ratio | 6.78 | 42.03 | 11.36 | 65.77 | -40.15 | |
P/B Ratio | 0.15 | 1.86 | 0.24 | 2.73 | 2.15 | |
PTB ratio | 0.15 | 1.86 | 0.24 | 2.73 | 2.15 | |
EV to sales | -1.16 | 3.07 | -0.7 | 5.18 | 4.06 | |
Enterprise value over EBITDA | -4.44 | 11.68 | -2.16 | 15.78 | 15.1 | |
EV to operating cash flow | -4.85 | 12.78 | -1.94 | 14.45 | 16.41 | |
EV to free cash flow | -12.39 | 32.61 | -7.59 | 56.45 | -35.73 | |
Earnings yield | 0.32 | 0.05 | 0.25 | 0.04 | 0.04 | |
Free cash flow yield | 0.15 | 0.02 | 0.09 | 0.02 | -0.02 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -6.87 | -3.37 | -5.4 | -2.61 | -1.87 | |
Current ratio | 5.35 | 5.35 | 4.47 | 4.47 | 3.67 | |
Interest coverage | 0 | 80.2 | 0 | 45.99 | 72.48 | |
Income quality | 1.19 | 1.19 | 1.36 | 1.36 | 1.25 | |
Dividend Yield | 0.2 | 0.03 | 0.06 | 0.01 | 0.04 | |
Payout ratio | 0.64 | 0.64 | 0.23 | 0.23 | 0.95 | |
Sales general and administrative to revenue | 0.03 | 0.02 | 0.03 | 0.02 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.61 | -0.61 | -0.74 | -0.74 | -1.46 | |
Capex to revenue | -0.15 | -0.15 | -0.27 | -0.27 | -0.36 | |
Capex to depreciation | -3.56 | -2.86 | -4.9 | -5.91 | -6.34 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | -0.17 | |
Graham number | 67.68 | 9.59 | 83.49 | 11.93 | 10.62 | |
ROIC | 0.04 | 0.07 | 0.05 | 0.1 | 0.08 | |
Return on tangible assets | 0.04 | 0.07 | 0.05 | 0.09 | 0.07 | |
Graham Net | 12.47 | 1.25 | 9.18 | 1.04 | 0.4 | |
Working capital | 2.4B | 2.4B | 2.5B | 2.5B | 2.02B | |
Tangible asset value | 5.63B | 5.63B | 6.27B | 6.27B | 6.3B | |
Net current asset value | 1.3B | 1.3B | 1.33B | 1.33B | 783.8M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 162.25M | 181.6M | 90.8M | 65.05M | 0 | |
Average payables | 561.05M | 523.7M | 524.4M | 612.8M | 0 | |
Average inventory | 381.25M | 373.2M | 393.4M | 413.6M | 0 | |
Days sales outstanding | 12.32 | 6.16 | 0 | 4.12 | 22.84 | |
Days payables outstanding | 47.47 | 23.42 | 49.09 | 32.41 | 24.12 | |
Days of inventory on hand | 33.83 | 16.69 | 38.67 | 19.14 | 19.85 | |
Receivables turnover | 7.31 | 14.62 | 1.42B | 21.84 | 3.94 | |
Payables turnover | 1.9 | 3.84 | 1.83 | 2.78 | 3.73 | |
Inventory turnover | 2.66 | 5.39 | 2.33 | 4.7 | 4.53 | |
ROE | 0.05 | 0.1 | 0.06 | 0.12 | 0.09 | |
Capex per share | -2.25 | -0.45 | -4.36 | -0.88 | -1.25 |
DRD.JO Frequently Asked Questions
What is DRDGOLD Limited stock symbol ?
DRDGOLD Limited is a ZA stock and trading under the symbol DRD.JO
What is DRDGOLD Limited stock quote today ?
DRDGOLD Limited stock price is $1641 today.
Is DRDGOLD Limited stock public?
Yes, DRDGOLD Limited is a publicly traded company.